Login to Your Account

Avexxin seeks to solve vexation of inflammation

By Marie Powers
News Editor

Friday, January 20, 2017

Avexxin AS is a testament to perseverance. Over several decades, Berit Johansen, the company's chief scientific officer, conducted basic research into the chronic inflammatory process.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription